About Ege Universitesi Tip Fakultesi
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
6
Janssen Research & Development, LLC
5
Bayer
4
Boehringer Ingelheim
3
Hoffmann-La Roche
3
Pfizer
3
Merck Sharp & Dohme LLC
2
Protagonist Therapeutics, Inc.
2
Abbott Nutrition
1
Baxalta now part of Shire
1
Eisai Inc.
1
Clinical Trials at Ege Universitesi Tip Fakultesi
During the past decade, Ege Universitesi Tip Fakultesi conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 11 clinical trials were completed, i.e. on
average, 34.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
2005-10-01
2008-10-01
Completed
1,683
A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.
2002-05-01
Completed
653
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
2009-07-09
2019-10-04
Completed
2,840
Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B
2011-09-01
2014-04-01
Completed
25
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
A Phase I/II Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
2012-12-01
2022-11-01
Active, not recruiting
191
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
2013-11-26
2016-10-27
Completed
113
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ege Universitesi Tip Fakultesi" #1 sponsor was "Amgen" with 6 trials, followed by "Janssen Research & Development, LLC" with 5 trials
sponsored, "Bayer" with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Hoffmann-La Roche"
with 3 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ege Universitesi Tip Fakultesi"
#1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Ege Universitesi Tip Fakultesi
According to Clinical.Site data, the most researched conditions in "Ege Universitesi Tip Fakultesi" are
"Hemophilia A" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Ineffective Erythropoiesis" (2 trials), "Myelofibrosis" (2 trials) and "β-thalassemia" (2 trials). Many other conditions were trialed in "Ege Universitesi Tip Fakultesi" in a lesser frequency.
Clinical Trials Intervention Types at Ege Universitesi Tip Fakultesi
Most popular intervention types in "Ege Universitesi Tip Fakultesi" are "Drug" (33 trials), "Biological" (8 trials) and "Other" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Pembrolizumab" (4 trials), "Cyclophosphamide" (3 trials), "Doxorubicin" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Ege Universitesi Tip Fakultesi
The vast majority of trials in "Ege Universitesi Tip Fakultesi" are
36 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.
Clinical Trials Status at Ege Universitesi Tip Fakultesi
Currently, there are NaN active trials in "Ege Universitesi Tip Fakultesi".
undefined are not yet recruiting,
14 are recruiting,
11 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Ege Universitesi Tip Fakultesi,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Ege Universitesi Tip Fakultesi, 2 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 26 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".